Alzheimer’s disease is one of the toughest medical issues that disrupts a person's daily life. Thankfully, medical advances ...

Former Senate Republican Leader Mitch McConnell announced Thursday that he would not seek reelection to the Senate after his ...

Now, several publications and presentations at the recent Alzheimer’s Association International Conference have demonstrated that blood tests measuring amyloid and tau proteins have become much more ...

Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time.

A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving early Alzheimer’s diagnosis. Unlike amyloid-beta, tau neurofibrillary ...

These various tests are at different stages of validation – assuring they’re accurate across many different populations. And, for each protein, there are several different met ...

There are two significant, nonscientific obstacles – a shortage of funding and patent law – that will require concerted effort by scientists, concerned citizens, society and our lawmakers to overcome.

Dr. Tim Rittman, a neurology consultant, highlights lesser-known early symptoms of dementia such as mild forgetfulness, ...

A blood test to detect the early signs of a type of dementia before it develops will be trialled across the UK in a study led ...

Researchers at Trinity College Dublin, the Tallaght Institute of Memory and Cognition and St James’s Hospital, Dublin are ...

EXPERT VERDICT: 'Chaga mushrooms are rich in an amino acid called ergothioneine, a unique compound humans cannot make,' says ...

Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...